Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil

Pediatric Blood and Cancer

Volumn 47, Issue 1, 2006, Pages 56-60

  Pianovski, Mara A D ^a   Maluf, Eliane M C P ^a   De Carvalho, Denise S ^a   Ribeiro, Raul C ^b   Rodriguez Galindo, Carlos ^b   Boffetta, Paolo ^c   Zancanella, Patrícia ^a   Figueiredo, Bonald C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Adrenocortical cancer; Children; Mortality

Indexed keywords

ADOLESCENT; ADRENAL CORTEX TUMOR; ARTICLE; BRAZIL; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH CERTIFICATE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; GERM LINE; GROUPS BY AGE; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; BRAZIL; CHILD; CHILD, PRESCHOOL; GENES, P53; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MUTATION; NEUROBLASTOMA; SURVIVAL RATE;

EID: 33646869990     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20624     Document Type: Article

References (39)

1. Parkin DM, Kramárová E, Draper GJ, et al. editors. International incidence of childhood cancer, vol. II, Lyon, France: IARC Scientific Publications, no. 144, 1999. 450p.
2. Birch JM, Blair V. Increase in childhood carcinomas in north-west England. Lancet 1988;1:833.
3. Bernstein L, Gurney JG. Carcinomas and other malignant epithelial neoplasms. In: Ries LAG, Smith MA, Gurney JG, et al. editors. Cancer and survival among children and adolescents: United States SEER program 1975-1995. Bethesda, MD: National Cancer Institute, 1999. pp 139-147.
4. Desandes E, Clavel J, Berger C, et al. Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer 2004;43: 749-757.
5. Marigo C, Muller H, Davies JNP. Survey of cancer in children admitted to a Brazilian charity hospital. J Natl Cancer Inst 1969; 43:1231-1240.
6. Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab 1997;82:2027-2031.
7. Latronico AC, Mendonca BB. Adrenocortical tumors-new perspectives. Arq Bras Endocrinol Metabol 2004;48:642-646.
8. Hirose PF, Capellanno AM, Oliveira A, et al. Adrenocortical tumors in children: The Brazilian experience in a single institution. J Clin Oncol 2005;23:A8506.
9. Pereira RM, Michalkiewicz E, Sandrini F, et al. Childhood adrenocortical tumors. Arq Bras Endocrinol Metabol 2004;48:651-658.
10. Sandrini F, Villani DP, Tucci S, et al. Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor. Horm Metab Res 2005;37:231-235.
11. Gatta G, Capocaccia R, Stiller C, et al. Childhood cancer survival trends in Europe: A EUROCARE Working Group Study. J Clin Oncol 2005;23:3742-3751.
12. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 2001;98: 9330-9335.
13. Latronico AC, Pinto EM, Domenice S, et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2002;86:4970-4973.
14. Figueiredo BC, Sandrini R, Zambetti GP, et al. Penetrance of adrenocortical tumors associated with the germline TP53 R337H Mutation. J Med Genet Epub ahead of print-7/20/05.
15. Brodeur CM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Lippincott: Williams & Wilkins. 2002. pp 895-937.
16. Waterhouse J, Muir CS, Shanmugaratnam K, et al. editors. Cancer incidence in five continents, vol. IV (IARC Scientific Publications, no. 42), Lyon: International Agency for Research on Cancer, 1982.
17. Parkin DM, Kramárová E. Materials and methods. In: Parkin DM, Kramárová E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA, editors. International incidence of childhood cancer, vol. II, Lyon, France: IARC Scientific Publications, no. 144, 1998. pp 3-14.
18. Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors. An analysis of 254 cases from the international pediatric adrenocortical tumor registry. J Clin Oncol 2004;22:838-845.
19. Ribeiro RC, Sandrini Neto RS, Schell MJ, et al. Adrenocortical carcinoma in children: A study of 40 cases. J Clin Oncol 1990;8: 67-74.
20. Michalkiewicz EL, Sandrini R, Bugg MF, et al. Clinical characteristics of small functioning adrenocortical tumors in children. Med Pediatr Oncol 1997;28:175-178.
21. Birch JM, Alston RD, McNally RJ, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001;20:4621-4628.
22. Kleihues P, Schauble B, zur HA, et al. Tumors associated with p53 germline mutations: A synopsis of 91 families. Am J Pathol 1997; 150:1-13.
23. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-1201.
24. Varley JM, McGown G, Thorncroft M, et al. Are there low-penetrance TP53 Alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 1999;65:995-1006.
25. Figueiredo BC, Ribeiro RC, Ellen M, et al. Multiple childhood adrenocortical tumors in six families from southern Brazil without Li-Fraumeni syndrome. Hormone Research 2000;53: 2-15.
26. DiGiammarino EL, Lee AS, Cadwell C, et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Natl Struct Biol 2002;9:12-16.
27. Lee AS, Galea C, DiGiammarino EL, et al. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant. J Mol Biol 2003;327:699-709.
28. Figueiredo BC, Stratakis CA, Sandrini R, et al. Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 1999;84:1116-1121.
29. Figueiredo BC, Cavalli LR, Pianovski MA, et al. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab 2005;90:615-619.
30. Longui CA, Lemos-Marini SH, Figueiredo B, et al. Inhibin alpha-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers. J Med Genet 2004;41:354-359.
31. Barreto JHS, Dórea MDF, Mendonça N. Carcinoma do córtex adrenal na infância. Arq Bras Endocrinol Metabol 2001;45:S383.
32. Smith MA, Ries LAG. Childhood Cancer: Incidence, survival, and mortality. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Lippincott: Williams & Wilkins 2002; pp 1-12.
33. Spix C, Aareleid T, Stiller C, et al. Survival of children with neuroblastoma: Time trends and regional differences in Europe, 1978-1992. Eur J Cancer 2001;37:722-729.
34. Bernstein ML, Leclerc JM, Bunin G, et al. A population based study of neuroblastoma incidence, survival, and mortality in North America (published erratum appears in J Clin Oncol 10: 1202, 1992). J Clin Oncol 1992;10:323-329.
35. Dehner LP, Franciosi RA. Adrenocortical neoplasia in the pediatric age group. A clinicopathologic study of seven cases. In: Humphrey GB, Grindey GB, Dehner LP, editors. Adrenal and endocrine tumors in children. Adrenal cortical carcinoma and multiple endocrine neoplasia. Boston: Martinus Nijhoff Publishers, 1984. pp 291-302.
36. Stewart DR, Jones PHM, Jolleys A. Carcinoma of the adrenal gland in children. J Pediatr Surg 1974;9:59-67.
37. Gao RN, Levy IG, Woods WG, et al. Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers. Cancer Causes and Control 1997;8:745-754.
38. Huddart SN, Muir KR, Parkes S, et al. Neuroblastoma: A 32 year population-based study-implications for screening. Med Ped Oncol 1993;21:96-102.
39. Terracini B, Coebergh JW, Gatta G, et al. Childhood cancer survival in Europe: An overview. Eur J Cancer 2001;37:810-816.